Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Oral Antidiabetic (OAD) Treatment Market Size Growth Rate by Type (2014-2025) 1.4.2 Sulphonylureas 1.4.3 Biguanides 1.4.4 Intestinal α-Glucosidase Inhibitors 1.4.5 Others 1.5 Market by Application 1.5.1 Global Oral Antidiabetic (OAD) Treatment Market Share by Application (2014-2025) 1.5.2 Hospital 1.5.3 Clinics 1.5.4 Diabetics Treatment Centres 1.5.5 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Oral Antidiabetic (OAD) Treatment Market Size 2.2 Oral Antidiabetic (OAD) Treatment Growth Trends by Regions 2.2.1 Oral Antidiabetic (OAD) Treatment Market Size by Regions (2014-2025) 2.2.2 Oral Antidiabetic (OAD) Treatment Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Oral Antidiabetic (OAD) Treatment Market Size by Manufacturers 3.1.1 Global Oral Antidiabetic (OAD) Treatment Revenue by Manufacturers (2014-2019) 3.1.2 Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Oral Antidiabetic (OAD) Treatment Market Concentration Ratio (CR5 and HHI) 3.2 Oral Antidiabetic (OAD) Treatment Key Players Head office and Area Served 3.3 Key Players Oral Antidiabetic (OAD) Treatment Product/Solution/Service 3.4 Date of Enter into Oral Antidiabetic (OAD) Treatment Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Oral Antidiabetic (OAD) Treatment Market Size by Type (2014-2019) 4.2 Global Oral Antidiabetic (OAD) Treatment Market Size by Application (2014-2019) 5 United States 5.1 United States Oral Antidiabetic (OAD) Treatment Market Size (2014-2019) 5.2 Oral Antidiabetic (OAD) Treatment Key Players in United States 5.3 United States Oral Antidiabetic (OAD) Treatment Market Size by Type 5.4 United States Oral Antidiabetic (OAD) Treatment Market Size by Application 6 Europe 6.1 Europe Oral Antidiabetic (OAD) Treatment Market Size (2014-2019) 6.2 Oral Antidiabetic (OAD) Treatment Key Players in Europe 6.3 Europe Oral Antidiabetic (OAD) Treatment Market Size by Type 6.4 Europe Oral Antidiabetic (OAD) Treatment Market Size by Application 7 China 7.1 China Oral Antidiabetic (OAD) Treatment Market Size (2014-2019) 7.2 Oral Antidiabetic (OAD) Treatment Key Players in China 7.3 China Oral Antidiabetic (OAD) Treatment Market Size by Type 7.4 China Oral Antidiabetic (OAD) Treatment Market Size by Application 8 Japan 8.1 Japan Oral Antidiabetic (OAD) Treatment Market Size (2014-2019) 8.2 Oral Antidiabetic (OAD) Treatment Key Players in Japan 8.3 Japan Oral Antidiabetic (OAD) Treatment Market Size by Type 8.4 Japan Oral Antidiabetic (OAD) Treatment Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Oral Antidiabetic (OAD) Treatment Market Size (2014-2019) 9.2 Oral Antidiabetic (OAD) Treatment Key Players in Southeast Asia 9.3 Southeast Asia Oral Antidiabetic (OAD) Treatment Market Size by Type 9.4 Southeast Asia Oral Antidiabetic (OAD) Treatment Market Size by Application 10 India 10.1 India Oral Antidiabetic (OAD) Treatment Market Size (2014-2019) 10.2 Oral Antidiabetic (OAD) Treatment Key Players in India 10.3 India Oral Antidiabetic (OAD) Treatment Market Size by Type 10.4 India Oral Antidiabetic (OAD) Treatment Market Size by Application 11 Central & South America 11.1 Central & South America Oral Antidiabetic (OAD) Treatment Market Size (2014-2019) 11.2 Oral Antidiabetic (OAD) Treatment Key Players in Central & South America 11.3 Central & South America Oral Antidiabetic (OAD) Treatment Market Size by Type 11.4 Central & South America Oral Antidiabetic (OAD) Treatment Market Size by Application 12 International Players Profiles 12.1 Pfizer 12.1.1 Pfizer Company Details 12.1.2 Company Description and Business Overview 12.1.3 Oral Antidiabetic (OAD) Treatment Introduction 12.1.4 Pfizer Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019) 12.1.5 Pfizer Recent Development 12.2 Eli Lilly 12.2.1 Eli Lilly Company Details 12.2.2 Company Description and Business Overview 12.2.3 Oral Antidiabetic (OAD) Treatment Introduction 12.2.4 Eli Lilly Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019) 12.2.5 Eli Lilly Recent Development 12.3 Merck 12.3.1 Merck Company Details 12.3.2 Company Description and Business Overview 12.3.3 Oral Antidiabetic (OAD) Treatment Introduction 12.3.4 Merck Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019) 12.3.5 Merck Recent Development 12.4 Sanofi 12.4.1 Sanofi Company Details 12.4.2 Company Description and Business Overview 12.4.3 Oral Antidiabetic (OAD) Treatment Introduction 12.4.4 Sanofi Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019) 12.4.5 Sanofi Recent Development 12.5 AstraZeneca 12.5.1 AstraZeneca Company Details 12.5.2 Company Description and Business Overview 12.5.3 Oral Antidiabetic (OAD) Treatment Introduction 12.5.4 AstraZeneca Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019) 12.5.5 AstraZeneca Recent Development 12.6 Glenmark 12.6.1 Glenmark Company Details 12.6.2 Company Description and Business Overview 12.6.3 Oral Antidiabetic (OAD) Treatment Introduction 12.6.4 Glenmark Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019) 12.6.5 Glenmark Recent Development 12.7 Novartis 12.7.1 Novartis Company Details 12.7.2 Company Description and Business Overview 12.7.3 Oral Antidiabetic (OAD) Treatment Introduction 12.7.4 Novartis Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019) 12.7.5 Novartis Recent Development 12.8 Boehringer Ingelheim 12.8.1 Boehringer Ingelheim Company Details 12.8.2 Company Description and Business Overview 12.8.3 Oral Antidiabetic (OAD) Treatment Introduction 12.8.4 Boehringer Ingelheim Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019) 12.8.5 Boehringer Ingelheim Recent Development 12.9 Novo Nordisk 12.9.1 Novo Nordisk Company Details 12.9.2 Company Description and Business Overview 12.9.3 Oral Antidiabetic (OAD) Treatment Introduction 12.9.4 Novo Nordisk Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019) 12.9.5 Novo Nordisk Recent Development 12.10 Mannkind 12.10.1 Mannkind Company Details 12.10.2 Company Description and Business Overview 12.10.3 Oral Antidiabetic (OAD) Treatment Introduction 12.10.4 Mannkind Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019) 12.10.5 Mannkind Recent Development 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Oral Antidiabetic (OAD) Treatment Key Market Segments Table Key Players Oral Antidiabetic (OAD) Treatment Covered Table Global Oral Antidiabetic (OAD) Treatment Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Oral Antidiabetic (OAD) Treatment Market Size Market Share by Type 2014-2025 Figure Sulphonylureas Figures Table Key Players of Sulphonylureas Figure Biguanides Figures Table Key Players of Biguanides Figure Intestinal α-Glucosidase Inhibitors Figures Table Key Players of Intestinal α-Glucosidase Inhibitors Figure Others Figures Table Key Players of Others Table Global Oral Antidiabetic (OAD) Treatment Market Size Growth by Application 2014-2025 (Million US$) Figure Hospital Case Studies Figure Clinics Case Studies Figure Diabetics Treatment Centres Case Studies Figure Others Case Studies Figure Oral Antidiabetic (OAD) Treatment Report Years Considered Table Global Oral Antidiabetic (OAD) Treatment Market Size 2014-2025 (Million US$) Figure Global Oral Antidiabetic (OAD) Treatment Market Size and Growth Rate 2014-2025 (Million US$) Table Global Oral Antidiabetic (OAD) Treatment Market Size by Regions 2014-2025 (Million US$) Table Global Oral Antidiabetic (OAD) Treatment Market Size by Regions 2014-2019 (Million US$) Table Global Oral Antidiabetic (OAD) Treatment Market Share by Regions 2014-2019 Figure Global Oral Antidiabetic (OAD) Treatment Market Share by Regions 2014-2019 Figure Global Oral Antidiabetic (OAD) Treatment Market Share by Regions 2019 Table Market Top Trends Table Global Oral Antidiabetic (OAD) Treatment Revenue by Manufacturers (2014-2019) (Million US$) Table Global Oral Antidiabetic (OAD) Treatment Market Share by Manufacturers (2014-2019) Figure Global Oral Antidiabetic (OAD) Treatment Market Share by Manufacturers in 2018 Table Global Oral Antidiabetic (OAD) Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Oral Antidiabetic (OAD) Treatment Product/Solution/Service Table Date of Enter into Oral Antidiabetic (OAD) Treatment Market Table Mergers & Acquisitions, Expansion Plans Table Global Oral Antidiabetic (OAD) Treatment Market Size by Type (2014-2019) (Million US$) Table Global Oral Antidiabetic (OAD) Treatment Market Size Share by Type (2014-2019) Figure Global Oral Antidiabetic (OAD) Treatment Market Size Market Share by Type (2014-2019) Table Global Oral Antidiabetic (OAD) Treatment Market Size by Application (2014-2019) (Million US$) Table Global Oral Antidiabetic (OAD) Treatment Market Size Share by Application (2014-2019) Figure Global Oral Antidiabetic (OAD) Treatment Market Size Market Share by Application (2014-2019) Figure Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Application in 2018 Figure United States Oral Antidiabetic (OAD) Treatment Market Size 2014-2019 (Million US$) Table United States Key Players Oral Antidiabetic (OAD) Treatment Revenue (2018-2019) (Million US$) Table United States Key Players Oral Antidiabetic (OAD) Treatment Market Share (2018-2019) Table United States Oral Antidiabetic (OAD) Treatment Market Size by Type (2014-2019) (Million US$) Table United States Oral Antidiabetic (OAD) Treatment Market Share by Type (2014-2019) Table United States Oral Antidiabetic (OAD) Treatment Market Size by Application (2014-2019) (Million US$) Table United States Oral Antidiabetic (OAD) Treatment Market Share by Application (2014-2019) Figure Europe Oral Antidiabetic (OAD) Treatment Market Size 2014-2019 (Million US$) Table Europe Key Players Oral Antidiabetic (OAD) Treatment Revenue (2018-2019) (Million US$) Table Europe Key Players Oral Antidiabetic (OAD) Treatment Market Share (2018-2019) Table Europe Oral Antidiabetic (OAD) Treatment Market Size by Type (2014-2019) (Million US$) Table Europe Oral Antidiabetic (OAD) Treatment Market Share by Type (2014-2019) Table Europe Oral Antidiabetic (OAD) Treatment Market Size by Application (2014-2019) (Million US$) Table Europe Oral Antidiabetic (OAD) Treatment Market Share by Application (2014-2019) Figure China Oral Antidiabetic (OAD) Treatment Market Size 2014-2019 (Million US$) Table China Key Players Oral Antidiabetic (OAD) Treatment Revenue (2018-2019) (Million US$) Table China Key Players Oral Antidiabetic (OAD) Treatment Market Share (2018-2019) Table China Oral Antidiabetic (OAD) Treatment Market Size by Type (2014-20189) (Million US$) Table China Oral Antidiabetic (OAD) Treatment Market Share by Type (2014-2019) Table China Oral Antidiabetic (OAD) Treatment Market Size by Application (2014-2019) (Million US$) Table China Oral Antidiabetic (OAD) Treatment Market Share by Application (2014-2019) Figure Japan Oral Antidiabetic (OAD) Treatment Market Size 2014-2019 (Million US$) Table Japan Key Players Oral Antidiabetic (OAD) Treatment Revenue (2018-2019) (Million US$) Table Japan Key Players Oral Antidiabetic (OAD) Treatment Market Share (2018-2019) Table Japan Oral Antidiabetic (OAD) Treatment Market Size by Type (2014-2019) (Million US$) Table Japan Oral Antidiabetic (OAD) Treatment Market Share by Type (2014-2019) Table Japan Oral Antidiabetic (OAD) Treatment Market Size by Application (2014-2019) (Million US$) Table Japan Oral Antidiabetic (OAD) Treatment Market Share by Application (2014-2019) Figure Southeast Asia Oral Antidiabetic (OAD) Treatment Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Oral Antidiabetic (OAD) Treatment Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Oral Antidiabetic (OAD) Treatment Market Share (2018-2019) Table Southeast Asia Oral Antidiabetic (OAD) Treatment Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Oral Antidiabetic (OAD) Treatment Market Share by Type (2014-2019) Table Southeast Asia Oral Antidiabetic (OAD) Treatment Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Oral Antidiabetic (OAD) Treatment Market Share by Application (2014-2019) Figure India Oral Antidiabetic (OAD) Treatment Market Size 2014-2019 (Million US$) Table India Key Players Oral Antidiabetic (OAD) Treatment Revenue (2018-2019) (Million US$) Table India Key Players Oral Antidiabetic (OAD) Treatment Market Share (2018-2019) Table India Oral Antidiabetic (OAD) Treatment Market Size by Type (2014-2019) (Million US$) Table India Oral Antidiabetic (OAD) Treatment Market Share by Type (2014-2019) Table India Oral Antidiabetic (OAD) Treatment Market Size by Application (2014-2019) (Million US$) Table India Oral Antidiabetic (OAD) Treatment Market Share by Application (2014-2019) Figure Central & South America Oral Antidiabetic (OAD) Treatment Market Size 2014-2019 (Million US$) Table Central & South America Key Players Oral Antidiabetic (OAD) Treatment Revenue (2018-2019) (Million US$) Table Central & South America Key Players Oral Antidiabetic (OAD) Treatment Market Share (2018-2019) Table Central & South America Oral Antidiabetic (OAD) Treatment Market Size by Type (2014-2019) (Million US$) Table Central & South America Oral Antidiabetic (OAD) Treatment Market Share by Type (2014-2019) Table Central & South America Oral Antidiabetic (OAD) Treatment Market Size by Application (2014-2019) (Million US$) Table Central & South America Oral Antidiabetic (OAD) Treatment Market Share by Application (2014-2019) Table Pfizer Company Details Table Pfizer Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019) (Million US$) Figure Pfizer Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2014-2019) Table Pfizer Recent Development Table Eli Lilly Company Details Table Eli Lilly Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019)(Million US$) Figure Eli Lilly Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2014-2019) Table Eli Lilly Recent Development Table Merck Company Details Table Merck Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019)(Million US$) Figure Merck Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2014-2019) Table Merck Recent Development Table Sanofi Company Details Table Sanofi Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019)(Million US$) Figure Sanofi Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2014-2019) Table Sanofi Recent Development Table AstraZeneca Company Details Table AstraZeneca Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019)(Million US$) Figure AstraZeneca Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2014-2019) Table AstraZeneca Recent Development Table Glenmark Company Details Table Glenmark Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019)(Million US$) Figure Glenmark Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2014-2019) Table Glenmark Recent Development Table Novartis Company Details Table Novartis Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019)(Million US$) Figure Novartis Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2014-2019) Table Novartis Recent Development Table Boehringer Ingelheim Company Details Table Boehringer Ingelheim Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019)(Million US$) Figure Boehringer Ingelheim Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2014-2019) Table Boehringer Ingelheim Recent Development Table Novo Nordisk Company Details Table Novo Nordisk Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019)(Million US$) Figure Novo Nordisk Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2014-2019) Table Novo Nordisk Recent Development Table Mannkind Company Details Table Mannkind Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019)(Million US$) Figure Mannkind Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2014-2019) Table Mannkind Recent Development Table Global Oral Antidiabetic (OAD) Treatment Market Size by Regions (Million US$) 2019-2025 Figure Global Oral Antidiabetic (OAD) Treatment Market Size Share by Regions (2019-2025) Figure Global Oral Antidiabetic (OAD) Treatment Market Size Share by Regions in 2025 Figure United States Oral Antidiabetic (OAD) Treatment Market Size Forecast (2019-2025)(Million USD) Figure Europe Oral Antidiabetic (OAD) Treatment Market Size Forecast (2019-2025)(Million USD) Figure China Oral Antidiabetic (OAD) Treatment Market Size Forecast (2019-2025)(Million USD) Figure Japan Oral Antidiabetic (OAD) Treatment Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Oral Antidiabetic (OAD) Treatment Market Size Forecast (2019-2025)(Million USD) Figure India Oral Antidiabetic (OAD) Treatment Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Oral Antidiabetic (OAD) Treatment Market Size Forecast (2019-2025)(Million USD) Table Global Oral Antidiabetic (OAD) Treatment Market Size by Product (2019-2025) (Million US$) Figure Global Oral Antidiabetic (OAD) Treatment Market Size by Product (2019-2025) Figure Global Oral Antidiabetic (OAD) Treatment Market Size by Product in 2025 Table Global Oral Antidiabetic (OAD) Treatment Market Size by Application (2019-2025) (Million US$) Figure Global Oral Antidiabetic (OAD) Treatment Market Size by Application (2019-2025) Figure Global Oral Antidiabetic (OAD) Treatment Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Pfizer Eli Lilly Merck Sanofi AstraZeneca Glenmark Novartis Boehringer Ingelheim Novo Nordisk Mannkind